Blood Advances·7 OctClinical Features and Outcomes of Therapy-Related Myeloid Neoplasms After CAR T-Cell TherapyStudy in peoplePopulationsPaper
Leukemia·25 AugTP53-mutant CHIP defines a pro-inflammatory phenotype and predicts adverse outcomes after CAR T-cell therapyCohort study of 104 peopleClonal hematopoiesis of indeterminate potentialPaper